肝硬化与感染

doi:10.3969/j.issn.1672-5069.2022.05.001

Abstract

Nan Yuemin, Li Jiazheng. Liver cirrhosis and infections: the state of the disease[J]. Journal of Practical Hepatology, 2022, 25(5): 609-611.

[1]Piano S, Tonon M, Angeli P. Changes in the epidemiology and management of bacterial infections in cirrhosis. Clin Mol Hepatol, 2021, 27(3): 437-445.
[2]乔杰, 王荣琦, 南月敏. 肝硬化患者感染的易感因素、类型及处理. 中华肝脏病杂志, 2021, 29(10): 1028-1030.
[3]Moon AM, Webb GJ, Aloman C, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry. J Hepatol, 2020, 73(3): 705-708.
[4]Piano S, Singh V, Caraceni P, et al. Epidemiology andeffects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology, 2019, 156(5): 1368-1380.
[5]Zhao R, Ma J, Li P, et al. Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study. Expert Rev Gastroenterol Hepatol, 2018, 12(11): 1167-1174.
[6]Piotrowski D, S czewska-Piotrowska A, Jaroszewicz J, et al. Lymphocyte-to-monocyte ratio as the best simple predictor of bacterial infection in patients with liver cirrhosis. Int J Environ Res Public Health, 2020, 17(5): 1727-1738.
[7]Tornai T, Vitalis Z, Sipeki N,et al. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Liver Int, 2016, 36(11): 1628-1638.
[8]中国研究型医院学会肝病专业委员会重症肝病学组, 中华医学会肝病学分会重型肝病与人工肝学组. 重症肝病合并侵袭性真菌感染诊治专家共识. 中华肝脏病杂志, 2022, 30(02): 159-168.
[9]Yao S, Wang Y, Sun Y,et al. Epidemiological investigation of hemophagocytic lymphohistiocytosis in China. Orphanet J Rare Dis, 2021, 16(1): 342-350.
[10] 李双双, 余健. 噬血细胞性淋巴组织细胞增多症的研究进展. 华南国防医学杂志, 2019, 33(02): 138-141.
[11] 中华医学会肝病学分会.肝硬化诊治指南. 现代医药卫生, 2020, 36(2): 320-330.
[12] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南. 实用肝脏病杂志, 2018, 21(1): 21-31.
[13] 中华医学会感染病学分会. 终末期肝病合并感染诊治专家共识(2021年版). 中华传染病杂志, 2022, 40 (04): 198-210.
[14] 中华医学会肝病学分会, 中华医学会消化病学分会.终末期肝病临床营养指南. 中华肝脏病杂志, 2019(5): 330-342.
[15] 中华医学会儿科学分会感染学组,全国儿童EB病毒感染协作组. 儿童EB病毒感染相关疾病的诊断和治疗原则专家共识. 中华儿科杂志, 2021, 59(11): 905-911.
[16] 李群辉, 李在村, 孙丽君, 等. 人类单纯疱疹病毒的研究及治疗进展. 中国艾滋病性病, 2017, 23(05): 468-470,474.
[17] 张潇潇, 杨杨, 赵文, 等. 肝硬化合并细菌性肺炎的危险因素及其预后分析. 中华肝脏病杂志, 2020, 28(07): 561-566.
[18] Cannon MD, Martin P, Carrion AF. Bacterial infection in patients with cirrhosis: Don't get bugged to death. Dig Dis Sci, 2020, 65(1): 31-37.

Liver cirrhosis and infections: the state of the disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Luo Nan, Li Rongkuan. Spontaneous bacterial peritonitis in patients with liver cirrhosis [J]. Journal of Practical Hepatology, 2022, 25(5): 616-619.
[2]	Wang Yushan, Kong Yin, Liu Yuanyuan, et al.. Different switching therapy for chronic hepatitis B patients with low-level viraemia : a single-center retrospective study [J]. Journal of Practical Hepatology, 2022, 25(5): 633-636.
[3]	Xu Huan,Tan Junyuan,Huang He,et al.. Antiviral response and changes of TLR4 and B7-H1 in peripheral blood mononuclear cells by peginterferon α-2a and entecavir combination therapy in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2022, 25(5): 637-640.
[4]	Wang Chunying, Qu Yaoning, Qiao Wei, et al.. Implication of serum HBV cccDNA and HBV pgRNA in patients with chronic hepatitis B receiving entecavir therapy [J]. Journal of Practical Hepatology, 2022, 25(5): 641-644.
[5]	Liu Yantong, Yao Yang, Lu Bo. Short-term efficacy of Heye Tiaozhi Shugan Decoction in dealing with patients with nonalcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2022, 25(5): 657-660.
[6]	Pan Fei, Shou Juan, Zhang Dongqing. Short-term efficacy of different statins in treatment of patients with nonalcoholic fatty liver disease and hyperlipidaemia [J]. Journal of Practical Hepatology, 2022, 25(5): 665-668.
[7]	Gong Hao, Huang Li, Zhang Qinghong, et al.. Diagnostic efficacy of urine microalbumin, β2-microglobulin and N-acetyl-beta-glucosaminidase levels for renal injury in patients with decompensated liver cirrhosis [J]. Journal of Practical Hepatology, 2022, 25(5): 681-684.
[8]	Li Ting,Mao Xiaorong, Zhang Xuemei, et al.. Comparison of incidence of portal vein thrombosis in cirrhotics with hypersplenism after undergoing splenectomy or TIPS [J]. Journal of Practical Hepatology, 2022, 25(5): 685-688.
[9]	Li Ji, Zhou Zhongsong, Gao Yufeng, et al.. Short-term clinical efficacy of microwave ablation under the guidance of ultrasound fusion imaging in the treatment of patients with small primary liver cancer [J]. Journal of Practical Hepatology, 2022, 25(5): 698-701.
[10]	Zhang Kai, Liu Peipei, Rao Shilei, et al.. Survival rates in patients with primary liver cancer and different gross tumor volumes after radiotherapy [J]. Journal of Practical Hepatology, 2022, 25(5): 710-713.
[11]	Li Qinghan,Zhen Zuojun,He Yintao. Short-term efficacy of TACE, RFA, anti-PD-1 antibody and apatinib combination in the treatment of patients with postoperative recurrent hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2022, 25(5): 714-717.
[12]	Zhou Yu, Geng Jinchao, Han Xue, et al.. Very short-term efficacy of radiofrequency ablation in treatment of patients with primary liver cancer [J]. Journal of Practical Hepatology, 2022, 25(5): 718-721.
[13]	Ren Wenyan, Zhao Sen, Zhuang Yan et al.. Short-term efficacy of intratumor blood aspiration and radiofrequency ablation in the treatment of patients with hepatic hemangioma [J]. Journal of Practical Hepatology, 2022, 25(5): 726-729.
[14]	Fang Jun, Wang An, Sun Xiuyong, et al.. Stepped operation of ERCP and thereafter laparoscopic cholecystectomy and laparoscopic common bile duct exploration in the treatment of elderly patients with common bile duct stones and gallbladder stones [J]. Journal of Practical Hepatology, 2022, 25(5): 730-733.
[15]	Dilidan.Nasier,Zhao Liang,Nijiati.Aibibul,et al.. Indwelling subcutaneous jejunal blind loop and Roux-en-Y choledochojejunostomy in treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2022, 25(5): 734-737.